Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells.

Xing-Dong Xu Lan Yang Li-Yun Zheng Yan-Yan Pan Zhi-Fei Cao Zhi-Qing Zhang Quan-Sheng Zhou Bo Yang Cong Cao

BMC Cancer

Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu, 215021, China.

Published: July 2016

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932722	PMC
http://dx.doi.org/10.1186/s12885-016-2401-3	DOI Listing

Publication Analysis

Top Keywords

erratum suberoylanilide

suberoylanilide hydroxamic

hydroxamic acid

acid inhibitor

inhibitor histone

histone deacetylase

deacetylase suppresses

suppresses vasculogenic

vasculogenic mimicry

mimicry proliferation

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!